Novadiscovery announces Nature Communications paper on modeling the disruption to respiratory clinical trials due to mitigation measures against COVID-19
Novadiscovery announces Nature Communications paper on modeling the disruption to respiratory clinical trials due to mitigation measures against COVID-19 Model uses virtual populations and in silico trials to show impact on clinical trials and suggest adaptations to trial design Lyon, France – 13 April 2022: Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict